Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 47869Generated: October 29, 2026

Hydrochloric Acid → 4-[N-[7-Chloro-3-methyl-2-(4-methyl-piperazin-1-yl)methyl-4-oxo-3,4-dihydroquinazolin-6-ylmethyl]-N-(prop-2-ynyl)amino]-N-[3-(1H-imidazol-1-yl)propyl)benzamide

https://huagongshe.com/reaction/47869

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
ReactantSodium HydroxideHCID 14798—
Reactant1H-Imidazole-1-propanamineHCID 78736—
ReactantPyBOPHCID 2724699—
ReactantTert-butyl 4-[n-[7-chloro-3-methyl-2-(4-methyl-piperazin-1-yl)methyl-4-oxo-3,4-dihydroquinazolin-6-ylmethyl]-n-(prop-2-ynyl)amino]benzoateHCID 22744294—
SolventWaterHCID 962—
SolventDimethylformamideHCID 6228—
SolventDichloromethaneHCID 6344—
SolventTrifluoroacetic acidHCID 6422—
Product4-[N-[7-Chloro-3-methyl-2-(4-methyl-piperazin-1-yl)methyl-4-oxo-3,4-dihydroquinazolin-6-ylmethyl]-N-(prop-2-ynyl)amino]-N-[3-(1H-imidazol-1-yl)propyl)benzamideHCID 11114675—

Reaction Conditions

Temperature0 °C

Reaction Steps

A solution of tert-butyl 4-[N-[7-chloro-3-methyl-2-(4-methyl-piperazin-1-yl)methyl-4-oxo-3,4-dihydroquinazolin-6-ylmethyl]-N-(prop-2-ynyl)amino]benzoate (0.082 g, 0.15 mmol) (Preparation Example 14) in dichloromethane (1.2 ml) and trifluoroacetic acid (1.6 ml) was stirred at room temperature for 55 min. The solvents were then removed in vacuo, and the residue was treated with dichloromethane/toluene, concentrated in vacuo to leave a pale yellow solid which was dried in vacuo over P2O5. This solid was dissolved in anhydrous DMF (1.8 ml) under argon. The solution was placed in an ice-bath and then a solution of 1-(3-(aminopropyl)imidazole (0.029 g, 0.23 mmol) in anhydrous DMF (0.2 ml) was added followed by PyBOP® (0.083 g, 0.16 mmol), and finally diusopropylethylamine (0.135 g, 1.05 mmol). The solution was stirred at 0° C. for 5 min, then the ice-bath was removed and stirring was continued under argon for 2.5 h. The clear solution was then partitioned between ethyl acetate (150 ml) and saturated aqueous sodium bicarbonate (80 ml). The organic layer was washed with more saturated aqueous sodium bicarbonate (80 ml), brine (80 ml), dried (Na2SO4) and concentrated in vacuo. Purification by column chromatography, on gradient elution with methanol in chloroform (15 to 20%), afforded a white solid. This was suspended in water (6 ml) and the pH was first adjusted to ˜1 with 0.5N HCl and then to ˜12 with 1N NaOH. The white solid was collected by filtration, washed with water, and dried in vacuo over P2O5 (0.036 g, 40%), mp>115° C. (softens); 1H-NMR (DMSO-d6) 1.91 (m, 2H, CONHCH2CH2CH2), 2.14 (s, 3H, N-Me piperazine), 2.30 (br s) and 2.49 br s (obscured)) (8H, N(CH2CH2)2N—), 3.18 (m, 2H, CONHCH2CH2CH2), 3.20 (s, 1H, C≡CH), 3.59, 3.61 (2×s, 5H, N3-Me and 2-CH2), 3.98 (t, J=6.84 Hz, 2H, CONHCH2CH2CH2) 4.37 (s, 2H, CH2C≡C), 4.76 (s, 2H, 6-CH2), 6.78 (d, J=8.5 Hz, 2H, 3,5′-ArH), 6.88, 7.19 (2×s, 2H, imidazole 4-H and 5-H), 7.64 (s, 1H, imidazole 2-H), 7.71 (d, J=8.2 Hz, 2H, 2′,6′-ArH), 7.81, 7.91 (2×s, 2H, 5-H, 8-H), 8.17 (t, J=5.0 Hz, 1H, CONH).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06699861B1
Source datasetuspto-grants-2004_03
ORD IDord-501f2426052d4c84bb3700aed7d2d63a
Source noteuspto-grants-2004_03